BOUYGUES CONSTRUCTION’S UK SUBSIDIARY CHOSEN TO CONSTRUCT A CANCER TREATMENT AND SURGERY CENTRE IN LONDON

Contacts presse

Hubert Engelmann
06 99 05 46 66
h.engelmann@bouygues-construction.com

Marie Pinot
07 61 64 22 81
m.pinot@bouygues-construction.com

Thursday 10 September 2015
University College London Hospitals (UCLH) NHS Foundation Trust has awarded Bouygues UK, a subsidiary of Bouygues Construction, a contract worth €257 million to design and build a new state-of-the-art hospital dedicated to advanced cancer treatment and surgery services in central London.
 
Chief Executive of UCLH, Sir Robert Naylor, said: “I am delighted that the contract to build this major new NHS facility has now been awarded. It will make a significant difference to the lives of hundreds of NHS patients every year and help us to advance our research into precision medicine.”
 
Madani Sow, Chairman and CEO of Bouygues UK, said: “This latest contract highlights our enviable reputation for building first-class healthcare facilities across the capital. We are proud to be working with UCLH on the delivery of what will be part of a vital new, national service for NHS patients here in the UK.”
 
Designed by architects Scott Tallon Walker in association with Edward Williams Architects, this treatment centre will be one of the first facilities of its kind in the country. It will form part of a new national high energy proton beam therapy programme run by the British National Health Service (NHS). Proton beam therapy is a highly targeted form of radiotherapy that is able to treat local cancers in hard-to-reach areas, potentially reducing damage to nearby tissue and other side effects.
 
UCLH is a provider of acute and specialist healthcare services for people from all across the UK and overseas. The new building, developed with funding from UCLH and the British Department of Health, will be built in close proximity to UCLH’s Cancer Centre and radiotherapy services, creating a leading hub for cancer treatment in central London.
 
The proton beam therapy facility will be located underground, and there will be five additional floors above ground offering care and treatment of blood cancer and short stay surgery. Bouygues Travaux Publics will contribute its expertise for the underground element of the project, which involves excavation of 25 metres as well as the installation of the latest proton beam therapy equipment - weighing around 120 tonnes below ground level.
 
The works have already begun and the centre is expected to begin treating patients in 2019. The project will achieve the “BIM Exemplar” label, attesting to its exemplary use of BIM (Building Information Modelling). It will also be targeting BREEAM® certification with “Excellent” status.
 
Operating in the United Kingdom for around 20 years, the Group has progressively grown its businesses in the sectors of property development (Bouygues Development), building (Bouygues UK), civil works (Bouygues Travaux Publics) and energy and services (Bouygues Energies & Services). The Group is strongly positioned on the United Kingdom healthcare market, where it has built and continues to operate several hospitals (North Middlesex, Central Middlesex, West Middlesex, Barnet and Broomfield).

Nos photos